In conclusion, elevated peripheral blood CD21low B cells and serum IL-4 and IL-21 levels were associated with higher articular disease activity in SSc patients, suggesting a possible role in the pathogenesis of SSc joint involvement. This evidence concerns the gene IL21 and systemic sclerosis.